4131.TWO NeoCore Technology Co., Ltd.

Healthcare Biotechnology Taiwan OTC Exchange
30.55 TWD
Close of Nov 6, 2026
28.20 42.45
Market cap
TWD 1.22B
P/E
-
P/B
4.25x
ROE
-1.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 4131.TWO undervalued?

Graham number

The Graham number of NeoCore Technology Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NeoCore Technology Co., Ltd. fundamental analysis

No fundamental analysis for NeoCore Technology Co., Ltd. yet.

NeoCore Technology Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NeoCore Technology Co., Ltd.

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety testing kits, including DR. Meat Kit, DR. Food-Ent kit, rapid test kit, and ELISA kit; infectious disease testing, such as DR. HPV Genotyping IVD Kit, DR. MTBC Screen IVD Kit, and DR. Microorganism IVD Kit (Non-sterile); and biochip instruments and equipment, including DR. AiM Reader, DR.Mini Oven, and DR.Fluidic Stat…

Full company profile